Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Wockhardt Ltd recalls hypertension drug in US market-Business Standard


Thursday, 5 Jun 2014 06:26am EDT 

Wockhardt Ltd:Is recalling over 8,000 bottles of anti-hypertension drug Metoprolol Succinate extended-release tablets in the US market following failure of a dissolution test-Business Standard.According to US Food and Drug Administration (USFDA), Wockhardt USA Inc, a subsidiary of Mumbai-based firm is voluntarily recalling 8,712 bottles of the drug in the American market.The recall is due to the 'failure of dissolution test observed at three month time point', USFDA said.Comments from Wockhardt could not immediately be obtained. 

Company Quote

976.7
12.4 +1.29%
24 Dec 2014